MarkosWebWeb intelligence for the agentic economy

Sequence Bio

Active

Discovering the true signals of disease to power life-changing drugs.

sequencebio.comAI readiness report

What it does

90% of drug candidates fail, delaying help for those in need. We’re on a mission to change that. Better drug target discovery powered by the Newfoundland founder effect.

Its site says now · captured 2026-08-23

Sequence Bio | Discovering the True Signals of Disease

We study the genetic causes of inherited disease to push drug discovery forward with the right targets and predictors of drug response from the start.

Next to it in Healthcare and bio · genomics-driven drug discovery

  • ResistanceBioY Combinator W19

    We solve drug resistance for cancer

  • Nabla BioY Combinator S20

    We use AI to design antibodies for intractable diseases

  • OncoboxY Combinator S17

    Finding the right cancer drug for each patient.

  • CellChorusY Combinator S21

    The dynamic single-cell analysis company

  • FluoSpheraSOSV SOSV IndieBio NY 05

    Drug Discovery without animals

  • PerlaraY Combinator W16

    Perlara: building the YC for rare disease parents

  • AMPLY DiscoveryTechstars TS 2023

    AMPLY Discovery — Turning the Dark Genome into Novel Medicines

  • Gordion BioscienceTechstars TS 2023

    Gordion Bioscience